AAPG PE Ratio & Valuation, Is AAPG Overvalued

Historical Valuation

Ascentage Pharma Group International (AAPG) is now in the Undervalued zone, suggesting that its current forward PS ratio of 14.11 is considered Undervalued compared with the five-year average of -27.84. The fair price of Ascentage Pharma Group International (AAPG) is between 35.40 to 59.58 according to relative valuation method. Compared to the current price of 24.49 USD , Ascentage Pharma Group International By Undervalued By 30.82%.

Relative Value

Fair Zone

35.40-59.58

Current Price：24.49

30.82%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Ascentage Pharma Group International (AAPG) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Ascentage Pharma Group International (AAPG) has a current Price-to-Book (P/B) ratio of 95.17. Compared to its 3-year average P/B ratio of 138.46, the current P/B ratio is approximately -31.26% higher. Relative to its 5-year average P/B ratio of 138.46, the current P/B ratio is about -31.26% higher. Ascentage Pharma Group International (AAPG) has a Forward Free Cash Flow (FCF) yield of approximately -1.29%. Compared to its 3-year average FCF yield of -1.60%, the current FCF yield is approximately -19.50% lower. Relative to its 5-year average FCF yield of -1.60%, the current FCF yield is about -19.50% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for AAPG competitors is 37.85, providing a benchmark for relative valuation. Ascentage Pharma Group International Corp (AAPG.O) exhibits a P/S ratio of 14.11, which is -62.72% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of AAPG increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of AAPG in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is AAPG currently overvalued or undervalued?

Ascentage Pharma Group International (AAPG) is now in the Undervalued zone, suggesting that its current forward PS ratio of 14.11 is considered Undervalued compared with the five-year average of -27.84. The fair price of Ascentage Pharma Group International (AAPG) is between 35.40 to 59.58 according to relative valuation method. Compared to the current price of 24.49 USD, Ascentage Pharma Group International is Undervalued By 30.82%.

What is Ascentage Pharma Group International (AAPG) fair value?

AAPG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Ascentage Pharma Group International (AAPG) is between 35.40 to 59.58 according to relative valuation method.

How does AAPG's valuation metrics compare to the industry average?

The average P/S ratio for AAPG's competitors is 37.85, providing a benchmark for relative valuation. Ascentage Pharma Group International Corp (AAPG) exhibits a P/S ratio of 14.11, which is -62.72% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Ascentage Pharma Group International (AAPG) as of Mar 11 2026?

As of Mar 11 2026, Ascentage Pharma Group International (AAPG) has a P/B ratio of 95.17. This indicates that the market values AAPG at 95.17 times its book value.

What is the current FCF Yield for Ascentage Pharma Group International (AAPG) as of Mar 11 2026?

As of Mar 11 2026, Ascentage Pharma Group International (AAPG) has a FCF Yield of -1.29%. This means that for every dollar of Ascentage Pharma Group International's market capitalization, the company generates -1.29 cents in free cash flow.

What is the current Forward P/E ratio for Ascentage Pharma Group International (AAPG) as of Mar 11 2026?

As of Mar 11 2026, Ascentage Pharma Group International (AAPG) has a Forward P/E ratio of -28.16. This means the market is willing to pay $-28.16 for every dollar of Ascentage Pharma Group International's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Ascentage Pharma Group International (AAPG) as of Mar 11 2026?

As of Mar 11 2026, Ascentage Pharma Group International (AAPG) has a Forward P/S ratio of 14.11. This means the market is valuing AAPG at $14.11 for every dollar of expected revenue over the next 12 months.

AAPG Valuation